Katherine Sheldon

413 total citations
18 papers, 332 citations indexed

About

Katherine Sheldon is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Katherine Sheldon has authored 18 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Katherine Sheldon's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Mitochondrial Function and Pathology (4 papers). Katherine Sheldon is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Mitochondrial Function and Pathology (4 papers). Katherine Sheldon collaborates with scholars based in Canada, United States and Denmark. Katherine Sheldon's co-authors include Reuben Baumal, Jean Gariépy, Daniel Liu, John Ferguson, Alexander Marks, John H. Law, Harriette Kahn, James R. Ballinger, Denis Bailey and Michael Stratis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Bioconjugate Chemistry and Human Mutation.

In The Last Decade

Katherine Sheldon

18 papers receiving 317 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine Sheldon Canada 10 191 79 59 43 41 18 332
Sayoko Narahara Japan 15 241 1.3× 55 0.7× 44 0.7× 24 0.6× 52 1.3× 20 486
Yuxia Zhan United States 12 202 1.1× 53 0.7× 77 1.3× 20 0.5× 23 0.6× 20 425
Takashi Kon Japan 12 214 1.1× 24 0.3× 60 1.0× 33 0.8× 83 2.0× 37 443
Ibu Matsuzaki Japan 12 173 0.9× 14 0.2× 104 1.8× 50 1.2× 63 1.5× 37 428
D. N. Sang United States 12 108 0.6× 128 1.6× 70 1.2× 25 0.6× 18 0.4× 22 412
Lakmini Senavirathna United States 11 234 1.2× 13 0.2× 33 0.6× 143 3.3× 30 0.7× 20 447
Koichi Uno Japan 9 163 0.9× 101 1.3× 22 0.4× 28 0.7× 21 0.5× 10 324
Jingliang He China 13 103 0.5× 123 1.6× 7 0.1× 23 0.5× 20 0.5× 34 391
Annelie Lindström Sweden 10 107 0.6× 85 1.1× 152 2.6× 38 0.9× 26 0.6× 17 424
Tina Bjørnlund Bønsdorff Norway 11 78 0.4× 119 1.5× 41 0.7× 118 2.7× 31 0.8× 24 303

Countries citing papers authored by Katherine Sheldon

Since Specialization
Citations

This map shows the geographic impact of Katherine Sheldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine Sheldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine Sheldon more than expected).

Fields of papers citing papers by Katherine Sheldon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine Sheldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine Sheldon. The network helps show where Katherine Sheldon may publish in the future.

Co-authorship network of co-authors of Katherine Sheldon

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine Sheldon. A scholar is included among the top collaborators of Katherine Sheldon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine Sheldon. Katherine Sheldon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
4.
Tarnopolsky, Mark A., Brandon Meaney, Brian Robinson, Katherine Sheldon, & Richard G. Boles. (2013). Severe infantile leigh syndrome associated with a rare mitochondrial ND6 mutation, m.14487T>C. American Journal of Medical Genetics Part A. 161(8). 2020–2023. 14 indexed citations
5.
Boles, Richard G., Katherine Sheldon, & Rosario Rich Trifiletti. (2013). Novel disease associations and novel disease-associated genes elucidated among MitoCarta gene sequencing in 183 probands. Mitochondrion. 13(6). 928–929. 1 indexed citations
6.
Sheldon, Katherine, et al.. (1995). Labelling small quantities of monoclonal antibodies and their F(ab′)2 fragments with technetium-99m. Nuclear Medicine and Biology. 22(4). 451–457. 8 indexed citations
8.
Sheldon, Katherine, Daniel Liu, John Ferguson, & Jean Gariépy. (1995). Loligomers: design of de novo peptide-based intracellular vehicles.. Proceedings of the National Academy of Sciences. 92(6). 2056–2060. 71 indexed citations
9.
Ballinger, James R., Katherine Sheldon, IZZIE BOXEN, Charles Erlichman, & Victor Ling. (1995). Differences between accumulation of 99mTc-MIBI and 201Tl-thallous chloride in tumour cells: role of P-glycoprotein.. PubMed. 39(2). 122–8. 20 indexed citations
10.
Sheldon, Katherine, Reuben Baumal, & Alexander Marks. (1992). Targeting of [111In]biocytin to cultured ovarian adenocarcinoma cells using covalent monoclonal antibody—Streptavidin conjugates. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 43(11). 1399–1402. 2 indexed citations
11.
Ballinger, James R., et al.. (1992). Evaluation of reduction-mediated labelling of antibodies with technetium-99m. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 19(6). 607–609. 4 indexed citations
12.
Sheldon, Katherine, et al.. (1991). Imaging of human ovarian tumour xenografts in nude mice using a novel 111In-labelled monoclonal antibody (10B). International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(5). 519–526. 2 indexed citations
13.
Reilly, Raymond M., Katherine Sheldon, Alexander Marks, & Sylvain Houle. (1989). Labelling of monoclonal antibodies 10B, 8C, and M2A with Indium-111. International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes. 40(4). 279–283. 6 indexed citations
14.
Sheldon, Katherine, Alexander Marks, & Reuben Baumal. (1989). Sensitivity of multidrug resistant KB-C1 cells to an antibody-dextran-adriamycin conjugate.. PubMed. 9(3). 637–41. 11 indexed citations
15.
Sheldon, Katherine, et al.. (1988). Comparison of growth inhibition of a human ovarian adenocarcinoma cell line by free monoclonal antibodies and their corresponding antibody-recombinant ricin A chain immunotoxins.. PubMed. 8(4). 833–8. 4 indexed citations
16.
Sheldon, Katherine, Alexander Marks, & Reuben Baumal. (1987). Characterization of binding of four monoclonal antibodies to the human ovarian adenocarcinoma cell line HEY. Biochemistry and Cell Biology. 65(5). 423–428. 17 indexed citations
17.
Baumal, Reuben, John H. Law, Ronald N. Buick, et al.. (1986). Monoclonal antibodies to an epithelial ovarian adenocarcinoma: distinctive reactivity with xenografts of the original tumor and a cultured cell line.. PubMed. 46(8). 3994–4000. 28 indexed citations
18.
Bailey, Denis, Reuben Baumal, John H. Law, et al.. (1986). Production of a monoclonal antibody specific for seminomas and dysgerminomas.. Proceedings of the National Academy of Sciences. 83(14). 5291–5295. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026